You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTNM Exercise Disclosure
Stengone Carmine N. · SEC Form 4 · Filed Jul 1, 2026
Exercise
Calculated transaction value
$3.15K
Stengone Carmine N. CEO And President
CTNM
Transaction date
Jun 30, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 1 day later
CTNM daily price context
Close on/before transaction
$16.39
Jun 30, 2026
First close after public filing
$15.1
Jul 2, 2026
30-day return after filing
+2.58%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 2,500 shares @ $1.26
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-046653
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$170.81K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Contineum Therapeutics, Inc. CTNM | Exercise | Jun 30, 2026 | $7.58K |
| Contineum Therapeutics, Inc. CTNM Current | Exercise | Jun 30, 2026 | $3.15K |
| Contineum Therapeutics, Inc. CTNM | Sale | Jun 30, 2026 | $160.08K |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jun 30, 2026 | $0 |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jun 30, 2026 | $0 |